Arizcorreta, A <br/><br/>
T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.  [electronic resource] 

 -  Clinical and experimental immunology  Nov 2006 
 - 270-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0009-9104 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2249.2006.03220.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiretroviral Therapy, Highly Active<br/>Antiviral Agents--therapeutic use<br/>CD4-Positive T-Lymphocytes--drug effects<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Female<br/>Follow-Up Studies<br/>Gene Rearrangement, T-Lymphocyte<br/>HIV Infections--complications<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Leukocyte Common Antigens--blood<br/>Male<br/>Polyethylene Glycols--therapeutic use<br/>Prospective Studies<br/>Receptors, Antigen, T-Cell--genetics<br/>Recombinant Proteins<br/>Ribavirin--therapeutic use<br/>T-Lymphocyte Subsets--drug effects<br/>Thymus Gland--immunology<br/>Treatment Outcome